Chufen Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chufen Lin has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Jiaqi Li
Key Laboratory of Emergency and Trauma of Ministry of Education, Department of Cardiovascular Medicine, The First Affiliated Hospital of Hainan Medical University, Haikou, China
1 shared publication- Jin Liu
Department of Cardiology, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
1 shared publication Julan Wu
Department of Pathology, Hainan Women and Children Medical Center, Hainan Medical University, Haikou, China
1 shared publication- Junli Guo
Hainan Provincial Key Laboratory for Tropical Cardiovascular Diseases Research & Institute of Cardiovascular Diseases, Hainan Medical University, Haikou, China
1 shared publication Minfang Wu
Key Laboratory of Emergency and Trauma of Ministry of Education, Department of Cardiovascular Medicine, The First Affiliated Hospital of Hainan Medical University, Haikou, China
1 shared publication- Na Lu
Hainan Medical University, Haikou 570102, China
1 shared publication
Latest Publications
- Open Access
- 28 August 2025
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1585919
Predictive value of echocardiographic parameter of diastolic dysfunction (Ea/Aa) combined with electrocardiographic P-wave dispersion for the detection of early recurrence of atrial fibrillation after radiofrequency catheter ablation
Objective: To explore the predictive value of echocardiographic parameters of left-ventricular diastolic function combined with electrocardiographic P-wave dispersion (PWD) for early recurrence of atrial fibrillation (ERAF) after radiofrequency catheter ablation (RFCA).Methods: A total of 145 patients with atrial fibrillation who underwent their first RFCA at the Department of Cardiology, First Affiliated Hospital of Hainan Medical University, between January 2021 and December 2024, were enrolled in the study. The patients were followed up for 3 months after RFCA and divided into two groups, namely those with early recurrence and those without early recurrence. Within 2 h after the procedure, 12-lead electrocardiogram (ECGs) was recorded. The maximum P-wave duration (Pmax), minimum P-wave duration (Pmin), and PWD (the difference between Pmax and Pmin) were measured. Additionally, left-ventricular diastolic function parameters were obtained via echocardiography.Results: ECG monitoring revealed ERAF in 45 patients (31.03%) at 3-month follow-up after RFCA. Spearman correlation analysis showed that ERAF positively correlated with PWD (r = 0.68, P < 0.001) and negatively correlated with Ea/Aa ratio (r = −0.49, P < 0.001). Under the combination of Ea/Aa < 1 and PWD, the area under the receiver operating characteristic (ROC) curve for the combined prediction increased to 0.95 [95% confidence interval (CI) = 0.91–0.98], with a Youden index of 0.73 (sensitivity 83.83%, specificity 88.88%). The incidence of ERAF was significantly higher in the group with Ea/Aa ratio P < 0.001). The incidence of ERAF was significantly higher in the group with PWD ≥ 29.5 ms than in the group with PWD < 29.5 ms (65.08 vs. 4.88%, P < 0.001). Ea/Aa ratio and PWD were independently associated with ERAF [for Ea/Aa ratio, adjusted hazard ratio (HR) = 13.48, 95% CI = 3.49–52.05, P < 0.001; for PWD, adjusted HR = 0.23, 95% CI = 0.08–0.62, P = 0.037, respectively].Conclusion: Left-ventricular diastolic dysfunction parameters and PWD can effectively predict ERAF after RCAF. Ea/Aa < 1 and PWD ≥ 29.5 ms are strong and independent predictors of ERAF.
- 28 August 2025
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1585919
Open AccessPredictive value of echocardiographic parameter of diastolic dysfunction (Ea/Aa) combined with electrocardiographic P-wave dispersion for the detection of early recurrence of atrial fibrillation after radiofrequency catheter ablation
Objective: To explore the predictive value of echocardiographic parameters of left-ventricular diastolic function combined with electrocardiographic P-wave dispersion (PWD) for early recurrence of atrial fibrillation (ERAF) after radiofrequency catheter ablation (RFCA).Methods: A total of 145 patients with atrial fibrillation who underwent their first RFCA at the Department of Cardiology, First Affiliated Hospital of Hainan Medical University, between January 2021 and December 2024, were enrolled in the study. The patients were followed up for 3 months after RFCA and divided into two groups, namely those with early recurrence and those without early recurrence. Within 2 h after the procedure, 12-lead electrocardiogram (ECGs) was recorded. The maximum P-wave duration (Pmax), minimum P-wave duration (Pmin), and PWD (the difference between Pmax and Pmin) were measured. Additionally, left-ventricular diastolic function parameters were obtained via echocardiography.Results: ECG monitoring revealed ERAF in 45 patients (31.03%) at 3-month follow-up after RFCA. Spearman correlation analysis showed that ERAF positively correlated with PWD (r = 0.68, P < 0.001) and negatively correlated with Ea/Aa ratio (r = −0.49, P < 0.001). Under the combination of Ea/Aa < 1 and PWD, the area under the receiver operating characteristic (ROC) curve for the combined prediction increased to 0.95 [95% confidence interval (CI) = 0.91–0.98], with a Youden index of 0.73 (sensitivity 83.83%, specificity 88.88%). The incidence of ERAF was significantly higher in the group with Ea/Aa ratio P < 0.001). The incidence of ERAF was significantly higher in the group with PWD ≥ 29.5 ms than in the group with PWD < 29.5 ms (65.08 vs. 4.88%, P < 0.001). Ea/Aa ratio and PWD were independently associated with ERAF [for Ea/Aa ratio, adjusted hazard ratio (HR) = 13.48, 95% CI = 3.49–52.05, P < 0.001; for PWD, adjusted HR = 0.23, 95% CI = 0.08–0.62, P = 0.037, respectively].Conclusion: Left-ventricular diastolic dysfunction parameters and PWD can effectively predict ERAF after RCAF. Ea/Aa < 1 and PWD ≥ 29.5 ms are strong and independent predictors of ERAF.
- Open Access
- 24 October 2023
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 15 (1) , 1-12
Prognostic value of the prognostic nutritional index for patients with acute myocardial infarction undergoing percutaneous coronary intervention with variable glucose metabolism statuses: a retrospective cohort study
Background: The prognostic nutritional index (PNI) and different glucose metabolisms have been separately reported to be correlated with long-term prognosis in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI). However, PNI application in patients with an impaired glucose metabolism has not been well validated, especially in pre-diabetic patients. This study evaluated whether PNI influences a long-term risk of mortality along different glucose metabolism statuses. Methods: A total of 17,697 patients with AMI and a history of PCI were enrolled in this retrospective observational cohort study from January 2007 to December 2020. Three subgroups with different glucose metabolism statuses, including normal glucose regulation (NGR), pre-diabetes mellitus (pre-DM), and diabetes mellitus (DM), were divided into three groups according to the tertiles of PNI, respectively. Results: All-cause mortality occurred in 2613 (14.8%) patients within a median of 4.1 years of follow-up. Upon analyzing the Kaplan–Meier plots for the NGR, pre-DM, and DM groups, the incidence of all-cause or cardiovascular mortality in the low PNI (PNI-L, ≤ 42.7) subgroup was significantly higher than that in the median PNI (PNI-M, > 42.7 and ≤ 48.2) and high PNI (PNI-H, > 48.2) subgroups (all, P < 0.001). After adjusting for confounding factors, the hazard ratio (HR) for all-cause mortality in the PNI-L group significantly increased compared to that in the PNI-H subgroups of the NGR group (HR, 1.35; 95% CI 1.14–1.66; P < 0.001), pre-DM group (HR, 1.29; 95% CI 1.02–1.62; P < 0.001), and DM group (HR, 1.36; 95% CI 1.13–1.63; P < 0.001). Given that there was evidence of interactions between PNI and different glucose statuses (P for interaction < 0.001), patients were divided into nine subgroups, and we found that DM patients with PNI-L statuses had the highest risk of all-cause mortality compared to NGR patients with PNI-H statuses (HR, 1.69; 95% CI 1.42–2.01; P < 0.001). Conclusion: Lower PNI is a significant and independent risk factor for all-cause mortality in AMI patients undergoing PCI with different glucose metabolism statuses, and this risk further increases with DM compared to NGR or pre-DM statuses.
- 24 October 2023
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 15 (1) , 1-12
Open AccessPrognostic value of the prognostic nutritional index for patients with acute myocardial infarction undergoing percutaneous coronary intervention with variable glucose metabolism statuses: a retrospective cohort study
Background: The prognostic nutritional index (PNI) and different glucose metabolisms have been separately reported to be correlated with long-term prognosis in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI). However, PNI application in patients with an impaired glucose metabolism has not been well validated, especially in pre-diabetic patients. This study evaluated whether PNI influences a long-term risk of mortality along different glucose metabolism statuses. Methods: A total of 17,697 patients with AMI and a history of PCI were enrolled in this retrospective observational cohort study from January 2007 to December 2020. Three subgroups with different glucose metabolism statuses, including normal glucose regulation (NGR), pre-diabetes mellitus (pre-DM), and diabetes mellitus (DM), were divided into three groups according to the tertiles of PNI, respectively. Results: All-cause mortality occurred in 2613 (14.8%) patients within a median of 4.1 years of follow-up. Upon analyzing the Kaplan–Meier plots for the NGR, pre-DM, and DM groups, the incidence of all-cause or cardiovascular mortality in the low PNI (PNI-L, ≤ 42.7) subgroup was significantly higher than that in the median PNI (PNI-M, > 42.7 and ≤ 48.2) and high PNI (PNI-H, > 48.2) subgroups (all, P < 0.001). After adjusting for confounding factors, the hazard ratio (HR) for all-cause mortality in the PNI-L group significantly increased compared to that in the PNI-H subgroups of the NGR group (HR, 1.35; 95% CI 1.14–1.66; P < 0.001), pre-DM group (HR, 1.29; 95% CI 1.02–1.62; P < 0.001), and DM group (HR, 1.36; 95% CI 1.13–1.63; P < 0.001). Given that there was evidence of interactions between PNI and different glucose statuses (P for interaction < 0.001), patients were divided into nine subgroups, and we found that DM patients with PNI-L statuses had the highest risk of all-cause mortality compared to NGR patients with PNI-H statuses (HR, 1.69; 95% CI 1.42–2.01; P < 0.001). Conclusion: Lower PNI is a significant and independent risk factor for all-cause mortality in AMI patients undergoing PCI with different glucose metabolism statuses, and this risk further increases with DM compared to NGR or pre-DM statuses.